HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 88962 | 108106 | 82.3% | |
| HF 4 | 2011 | 96177 | 117170 | 82.1% | |
| HF 4 | 2012 | 103996 | 124029 | 83.9% | |
| HF 4 | 2013 | 111763 | 128852 | 86.7% | |
| HF004 | 2014 | 68309 | 74198 | 92.1% | |
| HF004 | 2015 | 76758 | 82782 | 92.7% | |
| HF004 | 2016 | 91883 | 99237 | 92.6% | |
| HF004 | 2017 | 106252 | 114782 | 92.6% | |
| HF004 | 2018 | 117688 | 127416 | 92.4% | |
| HF004 | 2019 | 133685 | 145593 | 91.8% | |
| HF004 | 2020 | 146495 | 160411 | 91.3% | |
| HF006 | 2021 | 185745 | 207623 | 89.5% | |
| HF006 | 2022 | 214494 | 226425 | 94.7% | |
| HF006 | 2023 | 250162 | 260661 | 96.0% |
